AMERICAN WELL CORPORATION |
Market Closed -
Nyse
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.360 USD | +3.20% |
|
-1.47% | -68.59% |
| 09-04 | American Well Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 01:50 PM | |
| 07-31 | American Well Corporation, Q2 2024 Earnings Call, Jul 31, 2024 |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Revenues | 149M | 245M | 253M | 277M | 259M | |
Total Revenues | 149M | 245M | 253M | 277M | 259M | |
Cost of Goods Sold, Total | 79.98M | 157M | 148M | 160M | 164M | |
Gross Profit | 68.88M | 88.48M | 104M | 117M | 94.76M | |
Selling General & Admin Expenses, Total | 100M | 221M | 168M | 222M | 209M | |
R&D Expenses | 53.94M | 84.41M | 107M | 138M | 106M | |
Depreciation & Amortization - (IS) | 7.76M | 10.15M | 16.09M | 26.15M | 31.49M | |
Other Operating Expenses, Total | 162M | 316M | 291M | 387M | 346M | |
Operating Income | -93.21M | -227M | -187M | -270M | -251M | |
Interest And Investment Income | 5.54M | 1.63M | 120K | 6.12M | 19.43M | |
Net Interest Expenses | 5.54M | 1.63M | 120K | 6.12M | 19.43M | |
Income (Loss) On Equity Invest. | - | -2.19M | -3.13M | -2.28M | -2.59M | |
Currency Exchange Gains (Loss) | - | - | - | - | -11K | |
EBT, Excl. Unusual Items | -87.68M | -228M | -190M | -266M | -234M | |
Merger & Related Restructuring Charges | -1.49M | - | -3.93M | - | - | |
Impairment of Goodwill | - | - | - | - | -436M | |
Legal Settlements | - | - | -2.18M | -5.58M | - | |
Other Unusual Items | - | - | 13.7M | - | -4.41M | |
EBT, Incl. Unusual Items | -89.17M | -228M | -182M | -272M | -675M | |
Income Tax Expense | -803K | 639K | -5.38M | 64K | 3.86M | |
Earnings From Continuing Operations | -88.37M | -229M | -177M | -272M | -679M | |
Net Income to Company | -88.37M | -229M | -177M | -272M | -679M | |
Minority Interest | 1.18M | 4.19M | 448K | 1.64M | 4.01M | |
Net Income - (IS) | -87.19M | -224M | -176M | -270M | -675M | |
Net Income to Common Incl Extra Items | -87.19M | -224M | -176M | -270M | -675M | |
Net Income to Common Excl. Extra Items | -87.19M | -224M | -176M | -270M | -675M | |
Per Share Items | ||||||
Net EPS - Basic | -42.39 | -45.32 | -13.88 | -19.72 | -47.5 | |
Basic EPS - Continuing Operations | -42.39 | -45.32 | -13.88 | -19.72 | -47.5 | |
Basic Weighted Average Shares Outstanding | 2.06M | 4.95M | 12.7M | 13.71M | 14.21M | |
Net EPS - Diluted | -42.39 | -45.32 | -13.88 | -19.72 | -47.5 | |
Diluted EPS - Continuing Operations | -42.39 | -45.32 | -13.88 | -19.72 | -47.5 | |
Diluted Weighted Average Shares Outstanding | 2.06M | 4.95M | 12.7M | 13.71M | 14.21M | |
Normalized Basic EPS | -26.07 | -27.93 | -9.3 | -12.02 | -10.03 | |
Normalized Diluted EPS | -26.07 | -27.93 | -9.3 | -12.02 | -10.03 | |
Supplemental Items | ||||||
EBITDA | -85.45M | -217M | -171M | -244M | -226M | |
EBITA | -87.22M | -219M | -173M | -246M | -227M | |
EBIT | -93.21M | -227M | -187M | -270M | -251M | |
EBITDAR | -78.8M | -211M | -165M | -239M | -222M | |
Effective Tax Rate - (Ratio) | 0.9 | -0.28 | 2.95 | -0.02 | -0.57 | |
Current Domestic Taxes | - | 97K | 41K | 22K | 404K | |
Current Foreign Taxes | - | 448K | 828K | 3.26M | 3.61M | |
Total Current Taxes | - | 545K | 869K | 3.28M | 4.02M | |
Deferred Domestic Taxes | - | 124K | -5.73M | - | - | |
Deferred Foreign Taxes | - | -30K | -516K | -3.21M | -158K | |
Total Deferred Taxes | - | 94K | -6.24M | -3.21M | -158K | |
Normalized Net Income | -53.62M | -138M | -118M | -165M | -143M | |
Supplemental Operating Expense Items | ||||||
Advertising Expense | 6.11M | 3.86M | 5.6M | 6.61M | 5.51M | |
Selling and Marketing Expenses | 47.67M | 55.1M | 66.15M | 81.63M | 82.05M | |
General and Administrative Expenses | 52.72M | 166M | 102M | 141M | 127M | |
Research And Development Expense From Footnotes | 53.94M | 84.41M | 107M | 138M | 112M | |
Net Rental Expense, Total | 6.65M | 6.63M | 5.62M | 4.97M | 4.29M | |
Stock-Based Comp., COGS (Total) | 536K | 1.09M | 1.66M | 1.6M | 1.68M | |
Stock-Based Comp., R&D Exp. (Total) | 1.48M | 4.79M | 7.61M | 10.24M | 10.35M | |
Stock-Based Comp., S&M Exp. (Total) | 2.42M | 4.15M | 7.67M | 7.18M | 8.61M | |
Stock-Based Comp., G&A Exp. (Total) | 7.7M | 108M | 26.88M | 50.12M | 51.4M | |
Stock-Based Comp., Other (Total) | - | - | - | - | 206K | |
Total Stock-Based Compensation | 12.14M | 118M | 43.81M | 69.14M | 72.25M |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Assets | ||||||
Cash And Equivalents | 138M | 942M | 746M | 539M | 372M | |
Short Term Investments | 39.95M | 99.96M | - | - | - | |
Total Cash And Short Term Investments | 178M | 1.04B | 746M | 539M | 372M | |
Accounts Receivable, Total | 32.73M | 45.3M | 51.38M | 58.37M | 54.15M | |
Notes Receivable | 1.78M | - | - | - | - | |
Total Receivables | 34.51M | 45.3M | 51.38M | 58.37M | 54.15M | |
Inventory | 3.1M | 9.13M | 7.53M | 8.74M | 6.65M | |
Prepaid Expenses | 7.16M | 14.06M | 20.28M | 19.57M | 14.48M | |
Restricted Cash | - | 1.1M | - | - | - | |
Other Current Assets, Total | 1.13M | 2.13M | 1.7M | 1.39M | 2.26M | |
Total Current Assets | 224M | 1.11B | 827M | 627M | 450M | |
Gross Property Plant And Equipment | 24.2M | 22.19M | 30.4M | 26.69M | 23.82M | |
Accumulated Depreciation | -9.6M | -11.74M | -11.74M | -12.17M | -12.8M | |
Net Property Plant And Equipment | 14.61M | 10.44M | 18.66M | 14.52M | 11.02M | |
Long-term Investments | - | 752K | 168K | - | 1.18M | |
Goodwill | 194M | 194M | 443M | 435M | - | |
Other Intangibles, Total | 63.54M | 55.53M | 152M | 135M | 120M | |
Accounts Receivable Long-Term | - | - | 781K | - | - | |
Deferred Charges Long-Term | 1.64M | 1.33M | 2.03M | 3.39M | 4.79M | |
Other Long-Term Assets, Total | 2.7M | 1.43M | 1.74M | 2.77M | 2.88M | |
Total Assets | 500M | 1.38B | 1.45B | 1.22B | 590M | |
Liabilities | ||||||
Accounts Payable, Total | 6.5M | 5.8M | 12.16M | 7.24M | 4.86M | |
Accrued Expenses, Total | 17.76M | 42.14M | 43.71M | 54.26M | 38.99M | |
Current Portion of Leases | 6.23M | 6.36M | 1.92M | 3.06M | 3.58M | |
Unearned Revenue Current, Total | 66.49M | 66.69M | 68.84M | 49.5M | 46.36M | |
Other Current Liabilities | 9.59M | - | 15M | - | - | |
Total Current Liabilities | 107M | 121M | 142M | 114M | 93.8M | |
Long-Term Leases | 7.16M | 1.3M | 14.69M | 11.79M | 8.21M | |
Unearned Revenue Non Current | 10.9M | 8.11M | 7.06M | 6.29M | 6.09M | |
Other Non Current Liabilities | 309K | 64K | 21.59M | 1.57M | 1.42M | |
Total Liabilities | 125M | 130M | 185M | 134M | 110M | |
Preferred Stock Convertible | 656M | - | - | - | - | |
Total Preferred Equity | 656M | - | - | - | - | |
Common Stock, Total | 50K | 2.36M | 2.62M | 2.77M | 2.88M | |
Additional Paid In Capital | 50.66M | 1.84B | 2.05B | 2.16B | 2.23B | |
Retained Earnings | -358M | -582M | -811M | -1.08B | -1.76B | |
Treasury Stock | -158K | -37.57M | - | - | - | |
Comprehensive Income and Other | 250K | 297K | -6.35M | -16.97M | -15.65M | |
Total Common Equity | -307M | 1.22B | 1.24B | 1.06B | 464M | |
Minority Interest | 26.26M | 22.06M | 21.62M | 19.97M | 15.97M | |
Total Equity | 375M | 1.25B | 1.26B | 1.08B | 480M | |
Total Liabilities And Equity | 500M | 1.38B | 1.45B | 1.22B | 590M | |
Supplemental Items | ||||||
ECS Total Shares Outstanding on Filing Date | 43.31M | 11.91M | 13.17M | 13.88M | 14.46M | |
ECS Total Common Shares Outstanding | 42.3M | 11.78M | 13.09M | 13.86M | 14.42M | |
Book Value / Share | -7.26 | 103.91 | 94.65 | 76.78 | 32.18 | |
Tangible Book Value | -565M | 975M | 644M | 494M | 344M | |
Tangible Book Value Per Share | -13.35 | 82.74 | 49.19 | 35.62 | 23.85 | |
Total Debt | 13.4M | 7.65M | 16.61M | 14.84M | 11.79M | |
Net Debt | -164M | -1.03B | -730M | -524M | -360M | |
Debt Equivalent Oper. Leases | 53.19M | 53.06M | 44.94M | 39.74M | 34.34M | |
Minority Interest, Total (Incl. Fin. Div) | 26.26M | 22.06M | 21.62M | 19.97M | 15.97M | |
Equity Method Investments, Total | - | 752K | 168K | - | 1.18M | |
Account Code - Inventory Valuation | 5 | 5 | 5 | 5 | 5 | |
Machinery, Total | 5.77M | 13.42M | 13.28M | 12.49M | 7.55M | |
Full Time Employees | 686 | 812 | 1.04K | 1.12K | 1.1K | |
Accumulated Allowance for Doubtful Accounts (Supple) | 686K | 1.56M | 1.81M | 1.88M | 2.29M |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Net Income | -87.19M | -224M | -176M | -270M | -675M | |
Depreciation & Amortization - CF | 1.77M | 2.15M | 2.16M | 1.53M | 651K | |
Amortization of Goodwill and Intangible Assets - (CF) | 5.99M | 8.01M | 13.93M | 24.64M | 24.61M | |
Depreciation & Amortization, Total | 7.76M | 10.15M | 16.09M | 26.17M | 25.26M | |
Amortization of Deferred Charges, Total - (CF) | 1.77M | 2.26M | 2.71M | 2.3M | 8.95M | |
Asset Writedown & Restructuring Costs | - | - | - | - | 436M | |
(Income) Loss On Equity Investments - (CF) | - | 2.19M | 3.13M | 2.28M | 2.59M | |
Stock-Based Compensation (CF) | 12.14M | 118M | 43.81M | 67.68M | 72.25M | |
Provision and Write-off of Bad Debts | 717K | 1.65M | 714K | 806K | 1.06M | |
Other Operating Activities, Total | -2.56M | -4.19M | -3.94M | 6.97M | -4.25M | |
Change In Accounts Receivable | 803K | -14.21M | -512K | -8.14M | 3.25M | |
Change In Inventories | -592K | -6.02M | 1.6M | -1.21M | 2.08M | |
Change In Accounts Payable | 1.16M | -707K | 5.55M | -4.78M | -2.36M | |
Change in Unearned Revenues | -16.15M | -2.17M | -9.37M | -19.74M | -3.46M | |
Change in Other Net Operating Assets | 260K | 4.67M | -24.98M | 5.77M | -15.02M | |
Cash from Operations | -81.89M | -112M | -142M | -192M | -148M | |
Capital Expenditure | -1.34M | -3.32M | -559K | -292K | -192K | |
Cash Acquisitions | -45.75M | - | -157M | - | - | |
Sale (Purchase) of Intangible assets | - | - | - | -10.16M | -15.06M | |
Investment in Marketable and Equity Securities, Total | 167M | -63.44M | 97.45M | -1.18M | -3.92M | |
Cash from Investing | 120M | -66.76M | -59.63M | -11.63M | -19.17M | |
Issuance of Common Stock | 1.04M | 878M | 22.4M | 8.24M | 2.73M | |
Repurchase of Common Stock | -158K | -37.57M | -15.04M | -360K | -586K | |
Issuance of Preferred Stock | 45.76M | 147M | - | - | - | |
Repurchase of Preferred Stock | - | - | - | - | - | |
Other Financing Activities, Total | - | -4.3M | -1.61M | -11.5M | - | |
Cash from Financing | 46.64M | 983M | 5.75M | -3.61M | 2.15M | |
Foreign Exchange Rate Adjustments | - | - | -84K | -305K | -1.14M | |
Net Change in Cash | 84.75M | 804M | -196M | -208M | -167M | |
Supplemental Items | ||||||
Cash Income Tax Paid (Refund) | 193K | 713K | 1.59M | 1.72M | 5M | |
Levered Free Cash Flow | -27.35M | -26.22M | -38.75M | -118M | -76.08M | |
Unlevered Free Cash Flow | -27.35M | -26.22M | -38.75M | -118M | -76.08M | |
Change In Net Working Capital | -10.58M | 11.53M | -15.91M | 35.9M | 10.26M |
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | -11.78 | -15.15 | -8.27 | -12.68 | -17.38 | |
Return on Total Capital | -15.34 | -17.31 | -9.22 | -14.22 | -19.74 | |
Return On Equity % | -23.68 | -28.21 | -14.1 | -23.21 | -86.85 | |
Return on Common Equity | 32.35 | -48.95 | -14.32 | -23.48 | -88.37 | |
Margin Analysis | ||||||
Gross Profit Margin % | 46.27 | 36.07 | 41.27 | 42.13 | 36.58 | |
SG&A Margin | 67.44 | 90.25 | 66.6 | 80.24 | 80.56 | |
EBITDA Margin % | -57.4 | -88.59 | -67.51 | -88.07 | -87.24 | |
EBITA Margin % | -58.59 | -89.46 | -68.36 | -88.62 | -87.49 | |
EBIT Margin % | -62.62 | -92.73 | -73.87 | -97.51 | -96.99 | |
Income From Continuing Operations Margin % | -59.36 | -93.22 | -69.93 | -98.15 | -262.18 | |
Net Income Margin % | -58.57 | -91.51 | -69.76 | -97.56 | -260.63 | |
Net Avail. For Common Margin % | -58.57 | -91.51 | -69.76 | -97.56 | -260.63 | |
Normalized Net Income Margin | -36.02 | -56.39 | -46.74 | -59.48 | -55.01 | |
Levered Free Cash Flow Margin | -18.37 | -10.69 | -15.33 | -42.45 | -29.37 | |
Unlevered Free Cash Flow Margin | -18.37 | -10.69 | -15.33 | -42.45 | -29.37 | |
Asset Turnover | ||||||
Asset Turnover | 0.3 | 0.26 | 0.18 | 0.21 | 0.29 | |
Fixed Assets Turnover | 16.83 | 19.58 | 17.37 | 16.71 | 20.28 | |
Receivables Turnover (Average Receivables) | 4.69 | 6.29 | 5.23 | 5.05 | 4.6 | |
Inventory Turnover (Average Inventory) | 28.48 | 25.64 | 17.83 | 19.72 | 21.35 | |
Short Term Liquidity | ||||||
Current Ratio | 2.1 | 9.2 | 5.84 | 5.49 | 4.79 | |
Quick Ratio | 1.97 | 8.98 | 5.63 | 5.23 | 4.54 | |
Operating Cash Flow to Current Liabilities | -0.77 | -0.93 | -1 | -1.69 | -1.58 | |
Days Sales Outstanding (Average Receivables) | 77.86 | 58.22 | 69.79 | 72.26 | 79.27 | |
Days Outstanding Inventory (Average Inventory) | 12.82 | 14.28 | 20.48 | 18.51 | 17.09 | |
Average Days Payable Outstanding | 24.3 | 13.83 | 22.31 | 21.9 | 13.61 | |
Cash Conversion Cycle (Average Days) | 66.37 | 58.67 | 67.96 | 68.87 | 82.75 | |
Long Term Solvency | ||||||
Total Debt/Equity | 3.57 | 0.61 | 1.32 | 1.37 | 2.45 | |
Total Debt / Total Capital | 3.45 | 0.61 | 1.3 | 1.35 | 2.4 | |
LT Debt/Equity | 1.91 | 0.1 | 1.17 | 1.09 | 1.71 | |
Long-Term Debt / Total Capital | 1.84 | 0.1 | 1.15 | 1.07 | 1.67 | |
Total Liabilities / Total Assets | 25 | 9.48 | 12.79 | 10.98 | 18.57 | |
Total Debt / EBITDA | -0.17 | -0.04 | -0.1 | -0.06 | -0.05 | |
Net Debt / EBITDA | 2.08 | 4.91 | 4.42 | 2.19 | 1.62 | |
Total Debt / (EBITDA - Capex) | -0.17 | -0.04 | -0.1 | -0.06 | -0.05 | |
Net Debt / (EBITDA - Capex) | 2.05 | 4.83 | 4.41 | 2.19 | 1.62 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | 30.63 | 64.77 | 3.07 | 9.65 | -6.55 | |
Gross Profit, 1 Yr. Growth % | 24.46 | 28.45 | 17.9 | 11.94 | -18.85 | |
EBITDA, 1 Yr. Growth % | 75.86 | 154.28 | -21.33 | 45.92 | -7.42 | |
EBITA, 1 Yr. Growth % | 73.77 | 151.58 | -21.12 | 44.97 | -7.73 | |
EBIT, 1 Yr. Growth % | 72.87 | 144 | -17.77 | 47.39 | -7.04 | |
Earnings From Cont. Operations, 1 Yr. Growth % | 68.92 | 158.73 | -22.68 | 53.9 | 149.63 | |
Net Income, 1 Yr. Growth % | 65.53 | 157.41 | -21.43 | 53.36 | 149.66 | |
Normalized Net Income, 1 Yr. Growth % | 65.93 | 157.92 | -14.44 | 42.08 | -13.57 | |
Diluted EPS Before Extra, 1 Yr. Growth % | 63.29 | 6.92 | -69.37 | 42.08 | 140.87 | |
Accounts Receivable, 1 Yr. Growth % | 6.34 | 38.39 | 13.42 | 13.62 | -7.24 | |
Inventory, 1 Yr. Growth % | 23.57 | 194.07 | -17.51 | 16.03 | -23.86 | |
Net Property, Plant and Equip., 1 Yr. Growth % | 374.75 | -28.5 | 78.62 | -22.17 | -24.08 | |
Total Assets, 1 Yr. Growth % | 2.16 | 175.39 | 5.03 | -15.79 | -51.57 | |
Tangible Book Value, 1 Yr. Growth % | 36.19 | -272.66 | -33.92 | -23.36 | -30.32 | |
Common Equity, 1 Yr. Growth % | 32.47 | -498.58 | 1.24 | -14.15 | -56.37 | |
Cash From Operations, 1 Yr. Growth % | 10.66 | 37.33 | 25.85 | 35.88 | -22.87 | |
Capital Expenditures, 1 Yr. Growth % | -29.98 | 147.98 | -83.15 | -47.76 | -34.25 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | -4.15 | 49.06 | 221.01 | -35.33 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | -4.15 | 49.06 | 221.01 | -35.33 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | 46.71 | 30.32 | 6.31 | 1.23 | |
Gross Profit, 2 Yr. CAGR % | - | 26.44 | 23.06 | 14.88 | -4.69 | |
EBITDA, 2 Yr. CAGR % | - | 111.46 | 41.32 | 6.08 | 21.3 | |
EBITA, 2 Yr. CAGR % | - | 109.08 | 40.76 | 5.89 | 20.63 | |
EBIT, 2 Yr. CAGR % | - | 105.38 | 41.54 | 9.16 | 21.69 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | 109.06 | 41.44 | 9.09 | 96.01 | |
Net Income, 2 Yr. CAGR % | - | 106.42 | 42.21 | 9.77 | 95.68 | |
Normalized Net Income, 2 Yr. CAGR % | - | 106.87 | 48.44 | 9.34 | 15.15 | |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | 32.13 | -42.78 | -34.03 | 84.99 | |
Accounts Receivable, 2 Yr. CAGR % | - | 21.31 | 25.29 | 13.52 | 2.66 | |
Inventory, 2 Yr. CAGR % | - | 90.62 | 55.75 | -2.17 | -6.01 | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | 84.24 | 13.01 | 17.91 | -23.13 | |
Total Assets, 2 Yr. CAGR % | - | 67.73 | 70.07 | -5.96 | -36.14 | |
Tangible Book Value, 2 Yr. CAGR % | - | 53.35 | 6.81 | -28.84 | -26.92 | |
Common Equity, 2 Yr. CAGR % | - | 129.78 | 100.87 | -6.78 | -38.8 | |
Cash From Operations, 2 Yr. CAGR % | - | 23.27 | 31.47 | 30.77 | 2.38 | |
Capital Expenditures, 2 Yr. CAGR % | - | 31.77 | -35.36 | -70.33 | -41.39 | |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | 19.03 | 112.35 | 64.58 | |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | 19.03 | 112.35 | 64.58 | |
Compound Annual Growth Rate Over Three Years | ||||||
Total Revenues, 3 Yr. CAGR % | - | - | 30.42 | 23.03 | 1.84 | |
Gross Profit, 3 Yr. CAGR % | - | - | 23.53 | 19.24 | 2.31 | |
EBITDA, 3 Yr. CAGR % | - | - | 52 | 41.89 | 1.37 | |
EBITA, 3 Yr. CAGR % | - | - | 51 | 41.22 | 1.14 | |
EBIT, 3 Yr. CAGR % | - | - | 51.3 | 42.6 | 3.47 | |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | 50.06 | 45.48 | 43.75 | |
Net Income, 3 Yr. CAGR % |